Literature DB >> 15555880

Comparison of E-test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica.

Lore Lang1, Fernando García.   

Abstract

MIC distribution and susceptibility to four antimicrobial agents were determined by E-test for 94 Helicobacter pylori isolates from Costa Rica. Disk diffusion was evaluated as an alternative method to determine susceptibility and compared with the E-test results by linear regression analysis and an error-rate bounded method. Thirty-eight (40.4%) of the isolates were resistant to metronidazole, 5.3% to clarithromycin and 5.3% to amoxicillin. No isolate was resistant to tetracycline. Multiple resistance was found in 4.3% of the isolates. H. pylori isolates were categorised as resistant to amoxicillin, clarithromycin and tetracycline when inhibition diameters were less than 25, 21 and 25 mm, respectively, in the disk diffusion assay. A breakpoint diameter for metronidazole with disk diffusion could not be firmly established.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555880     DOI: 10.1016/j.ijantimicag.2004.07.009

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  9 in total

1.  Droplet Digital PCR-Based Detection of Clarithromycin Resistance in Helicobacter pylori Isolates Reveals Frequent Heteroresistance.

Authors:  Lu Sun; Sarah Talarico; Lena Yao; Lihua He; Steve Self; Yuanhai You; Huifang Zhang; Yiyao Zhang; Yongjun Guo; Guodong Liu; Nina R Salama; Jianzhong Zhang
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

2.  Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole.

Authors:  Hai-lun Zheng; Yong-mei Hu; Jun-jun Bao; Jian-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2010-03-22       Impact factor: 6.150

Review 3.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

Review 4.  Current understanding and management of Helicobacter pylori infection: an updated appraisal.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  F1000Res       Date:  2018-06-11

5.  In Vitro Inhibition of Helicobacter pylori Growth by Redox Cycling Phenylaminojuglones.

Authors:  Julio Benites; Héctor Toledo; Felipe Salas; Angélica Guerrero; David Rios; Jaime A Valderrama; Pedro Buc Calderon
Journal:  Oxid Med Cell Longev       Date:  2018-04-24       Impact factor: 6.543

6.  Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.

Authors:  Qin Ma; Hancong Li; Jing Liao; Zhaolun Cai; Bo Zhang
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

7.  Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion.

Authors:  Silvio Kazuo Ogata; Ana Cristina Gales; Elisabete Kawakami
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

8.  Prevalence of Helicobacter pylori vacA different genotypes in Isfahan, Iran.

Authors:  S Asghar Havaei; Parviz Mohajeri; Reza Khashei; Rasoul Salehi; Hamid Tavakoli
Journal:  Adv Biomed Res       Date:  2014-01-24

9.  Evaluation of Clarithromycin Resistance Among Iranian Helicobacter pylori Isolates by E-Test and Real-Time Polymerase Chain Reaction Methods.

Authors:  Mojdeh Hakemi Vala; Shirin Eyvazi; Hossein Goudarzi; Hamid Reza Sarie; Mehrdad Gholami
Journal:  Jundishapur J Microbiol       Date:  2016-03-19       Impact factor: 0.747

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.